Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery

Area of Science:

• Metabolic Surgery
• Obesity Medicine
• Endocrinology

Background:

• Obesity is a complex metabolic disorder often requiring bariatric surgery for effective treatment.
• The impact of beta cell function on post-bariatric surgery weight loss remains unclear.

Purpose of the Study:

• To investigate the relationship between beta cell function and total body weight loss (TBWL%) up to four years after bariatric surgery in patients with morbid obesity.

Main Methods:

• Retrospective longitudinal study of 1,561 morbidly obese patients (excluding those with baseline diabetes).
• Evaluated baseline Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), Homeostatic Model Assessment of Beta-cell function (HOMA-beta), and other insulin sensitivity indices.
• Linear regression models analyzed the association between baseline indices and TBWL% at 1, 2, 3, and 4 years post-surgery.

Main Results:

• Baseline HOMA-beta showed a significant negative association with TBWL% at years 2, 3, and 4 post-surgery.
• No significant association was found in the first year or with other insulin sensitivity indices.
• Baseline glycemia positively correlated with excess weight loss (EWL%) at years 2 and 3.

Conclusions:

• Beta cell function at baseline appears to be a significant predictor of long-term weight loss following bariatric surgery, particularly after the first year.
• These findings suggest beta cell function could be a valuable clinical predictor for bariatric surgery outcomes.